Postoperative radiation in esophageal squamous cell carcinoma and target volume delineation

被引:15
|
作者
Zhu, Yingming [1 ]
Li, Minghuan [1 ]
Kong, Li [1 ]
Yu, Jinming [1 ]
机构
[1] Shandong Univ, Shandong Canc Hosp & Inst, Dept Radiat Oncol, 440 Jiyan Rd, Jinan 250117, Shandong, Peoples R China
来源
ONCOTARGETS AND THERAPY | 2016年 / 9卷
关键词
adjuvant therapy; delineation of clinical target volume; postoperative locoregional recurrence; postoperative radiation; thoracic esophageal squamous cell carcinoma; INTENSITY-MODULATED RADIOTHERAPY; LYMPH-NODE DISSECTION; LUNG-CANCER; THORACIC ESOPHAGUS; CURATIVE RESECTION; CONFORMAL RADIOTHERAPY; RESECTABLE ESOPHAGEAL; RADICAL ESOPHAGECTOMY; PREMENOPAUSAL WOMEN; RECURRENCE PATTERN;
D O I
10.2147/OTT.S104221
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Esophageal cancer is the sixth leading cause of cancer death worldwide, and patients who are treated with surgery alone, without neoadjuvant therapies, experience frequent relapses. Whether postoperative therapies could reduce the recurrence or improve overall survival is still controversial for these patients. The purpose of our review is to figure out the value of postoperative adjuvant therapy and address the disputes about target volume delineation according to published data. Based on the evidence of increased morbidity and disadvantages on patient survival caused by postoperative chemotherapy or radiotherapy (RT) alone provided by studies in the early 1990s, the use of postoperative adjuvant therapies in cases of esophageal squamous cell carcinoma has diminished substantially and has been replaced gradually by neoadjuvant chemoradiation. With advances in surgery and RT, accumulating evidence has recently rekindled interest in the delivery of postoperative RT or chemoradiotherapy in patients with stage T3/T4 or N1 (lymph node positive) carcinomas after radical surgery. However, due to complications with the standard radiation field, a nonconforming modified field has been adopted in most studies. Therefore, we analyze different field applications and provide suggestions on the optimization of the radiation field based on the major sites of relapse and the surgical non-clearance area. For upper and middle thoracic esophageal carcinomas, the bilateral supraclavicular and superior mediastinal areas remain common sites of recurrence and should be encompassed within the clinical target volume. In contrast, a consensus has yet to be reached regarding lower thoracic esophageal carcinomas; the "standard" clinical target volume is still recommended. Further studies of larger sample sizes should focus on different recurrence patterns, categorized by tumor locations, refined classifications, and differing molecular biology, to provide more information on the delineation of target volumes.
引用
收藏
页码:4187 / 4196
页数:10
相关论文
共 50 条
  • [1] Characteristics of Lymph Node Recurrence After Radical Surgery and Their Value in Target Volume Delineation in Postoperative Radiation Therapy for Thoracic Esophageal Squamous Cell Carcinoma
    Liu, Q.
    Cai, X.
    Wu, B.
    Yu, W.
    Zhao, K.
    Fu, X.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S298 - S298
  • [2] Multimodality imaging for target volume delineation in oropharyngeal squamous cell carcinoma
    Bird, D.
    Speight, R.
    Sykes, J.
    Carey, B.
    Subesinghe, M.
    Ramasamy, S.
    Karakaya, E.
    Bayman, E.
    Scarsbrook, A.
    Prestwich, R.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2015, 115 : S31 - S32
  • [3] Interobserver variability in clinical target volume delineation in anal squamous cell carcinoma
    Kyung Su Kim
    Kwang-Ho Cheong
    Kyubo Kim
    Taeryool Koo
    Hyeon Kang Koh
    Ji Hyun Chang
    Ah Ram Chang
    Hae Jin Park
    [J]. Scientific Reports, 11
  • [4] Retropharyngeal nodes in squamous cell carcinoma of the oropharynx : implications for target volume delineation
    Bussels, B
    Hermans, R
    Rijnders, A
    Van den Bogaert, W
    [J]. RADIOTHERAPY AND ONCOLOGY, 2004, 73 : S179 - S179
  • [5] Interobserver variability in clinical target volume delineation in anal squamous cell carcinoma
    Kim, Kyung Su
    Cheong, Kwang-Ho
    Kim, Kyubo
    Koo, Taeryool
    Koh, Hyeon Kang
    Chang, Ji Hyun
    Chang, Ah Ram
    Park, Hae Jin
    [J]. SCIENTIFIC REPORTS, 2021, 11 (01)
  • [6] Explore the Radiotherapeutic Clinical Target Volume Delineation for Thoracic Esophageal Squamous Cell Carcinoma from the Pattern of Lymphatic Metastases
    Cheng, Jian
    Kong, Lingling
    Huang, Wei
    Li, Baosheng
    Li, Hongsheng
    Wang, Zhongtang
    Zhang, Jian
    Zhou, Tao
    Sun, Hongfu
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2013, 8 (03) : 359 - 365
  • [7] Pattern of relapse in surgical treated patients with thoracic esophageal squamous cell carcinoma and its possible impact on target delineation for postoperative radiotherapy
    Cai, Wen-Jie
    Xin, Pei-Ling
    [J]. RADIOTHERAPY AND ONCOLOGY, 2010, 96 (01) : 104 - 107
  • [8] Mapping of Cervical and Upper Mediastinal Lymph Node Recurrence for Guiding Clinical Target Delineation of Postoperative Radiotherapy in Thoracic Esophageal Squamous Cell Carcinoma
    Wang, Yichun
    Ye, Dongmei
    Kang, Mei
    Zhu, Liyang
    Yang, Mingwei
    Jiang, Jun
    Xia, Wanli
    Kang, Ningning
    Chen, Xiangcun
    Wang, Jie
    Wang, Fan
    [J]. FRONTIERS IN ONCOLOGY, 2021, 11
  • [9] The Prognosis and Feasibility of Extensive Clinical Target Volume in Postoperative Radiotherapy for Esophageal Squamous Cell Carcinoma: A Phase II Clinical Trial
    Zhang, Xiaofei
    Ai, Dashan
    Wang, Juanqi
    Chen, Yun
    Liu, Qi
    Deng, Jiaying
    Yang, Huanjun
    Nie, Yongzhan
    Chen, Weiwei
    Zhao, Weixin
    Zhao, Kuaile
    [J]. FRONTIERS IN ONCOLOGY, 2021, 11
  • [10] Precise delineation of clinical target volume for crossing-segments thoracic esophageal squamous cell carcinoma based on the pattern of lymph node metastases
    Dong, Yuanli
    Guan, Hui
    Huang, Wei
    Zhang, Zicheng
    Zhao, Dongbo
    Liu, Yang
    Zhou, Tao
    Li, Baosheng
    [J]. JOURNAL OF THORACIC DISEASE, 2015, 7 (12) : 2313 - 2320